When Obviousness Isn’t Obvious: The Purdue Pharma v. Accord Decision

The Supreme Court’s decision not to review Purdue Pharma L.P. v. Accord Healthcare, Inc. (No. 24-1132) leaves the Federal Circuit’s opinion (No. 2023-1953, Dec. 30, 2024) as the leading authority on the nexus requirement for objective indicia of non-obviousness. This CLE program revisits Purdue’s approach at both the trial and appellate levels, offering a close examination of how arguments on obviousness and secondary considerations were developed and received. Participants will explor... More Info